This clinical trial is focused on studying a heart condition known as ST-Elevated Myocardial Infarction (STEMI), which is a type of heart attack. The study is examining the effects of two medications: Acetylsalicylic Acid, commonly known as aspirin, and Prasugrel, an antiplatelet medication that helps prevent blood clots. The purpose of the study is to compare a treatment plan that starts with a combination of medications, including Prasugrel, for a short period, followed by Prasugrel alone, against a standard treatment plan.
Participants in the study will receive either the new treatment plan or the standard treatment plan. The study will last for about a year, during which the health of the participants will be monitored to see how well the treatments work. The study will also look at different ways of completing a procedure called revascularization, which helps restore blood flow to the heart. This will be done using either a method called Optical Coherence Tomography (OCT), which uses light waves to take pictures of the heart, or a standard method called angiography, which uses X-rays.
The main goal is to see if the new treatment plan is not worse than the standard plan in terms of preventing serious health problems like heart attacks, strokes, or bleeding. Additionally, the study aims to find out if using OCT for revascularization is better than using angiography in terms of the size of the area where a stent, a small tube used to keep blood vessels open, is placed. Participants will be followed up at different times to check for any major health events and to assess the success of the treatments.
Belgium 
Czechia 
Germany 
Italy 
The Netherlands 
